#Food and Drug Administration

FDA issued draft guidelines on a new blood donation policy; it now seeks public comment before the changes are finalized.

Older people, immunocompromised people and those with underlying health conditions can benefit most from additional shots.

Updated Pfizer-BioNTech and Moderna bivalent boosters contain spike proteins from the original and BA.4 and BA.5 omicron variants.

Updated boosters could go to the “worried well” who have good insurance rather than to those at highest risk.

The engineered protein vaccine was highly effective in a clinical trial but faced a long delay for authorization.

An unusual alliance among senators emerged in the push to allow for the importation of drugs from Canada and the United Kingdom.

After a long wait, the FDA authorizes Pfizer and Moderna vaccines for children as young as 6 months old.

The potentially lifesaving prescription drug buprenorphine is less available to women and Black and Latino people with opioid addiction.

The FDA is investigating the source of an outbreak that has led to 12 hospitalizations.

A study found that only 43% of clinical trials reported race and ethnicity. The FDA issued guidance to address these inequalities.

Immunocompromised people ages 12 and older are also eligible for an additional shot.

Testing advances made during the COVID-19 pandemic may lead to “test and treat” approaches for hepatitis C. But there’s a holdup.

Hepatitis of unknown cause (HUC) was the source of an outbreak linked to bottled alkaline water; 21 people got sick and one died.

Robert Califf headed the Food and Drug Administration for 10 months under Obama. Will he manage to implement his ideas this time around?

Third dose OK’d for people over 65, those at risk for severe COVID-19 and those at high risk of exposure to the coronavirus.

The committee voted against third shot for all adults, however, casting doubts on Biden’s booster plan.